Comparison 5. Orexin antagonists versus placebo: adverse events.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
5.1 Reporting ≥ 1 adverse event	2	323	Risk Ratio (M‐H, Fixed, 95% CI)	1.29 [0.83, 1.99]